Figure 4From: Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program Probabilistic sensitivity analysis of the incremental costs and effectiveness (QALYs) for RI-HSCT vs BT-ICT presented on a cost-effectiveness plane. RI-HSCT: Reduced intensity hematopoietic stem cell transplantation; BT-ICT: Blood transfusion combined with iron chelating therapy; QALYs: quality adjusted life-years.Back to article page